PharmaTelevision - Anne Lane, Executive Director, UCL Business Plc talks about the commercialization of innovation from within UCL by linking with commercial partners

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Anne Lane, Executive Director, UCL Business Plc talks about the commercialization of innovation from within UCL by linking with commercial partners

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Anne Lane, Executive Director of UCL Business plc

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

UCLB's Strategy of commercialisation of innovation

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at the LESI Conference in London, in 2011. On this show I have Anne Lane, who is Executive Director at University College London Business , welcome.

Anne Lane:

Hello.

Fintan Walton:

Anne, one of the things you've done at the Licensing Executive Society's International meeting here in London is to help make it all happen, but you actually have a much fuller job that you have which is the Executive Director at the University College London Business or UCLB?

Anne Lane:

Yes.

Fintan Walton:

Well first of all obviously UCLB 's role and responsibility is to commercialization of innovation that comes within University College London ?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

Anne Lane

Executive Director

Anne Lane has a PhD in medicine from UCL and an Executive MBA from Molson Business School, Montreal. After research at UCL and Harvard Medical School, Anne Lane worked for RTP Pharma Inc in Montreal, out-licensing and preparing valuations of the company's portfolio for public listing. Anne joined UCL Ventures in 2000 and acted as consultant for the National Transfer Centre in the US. She is now Executive Director of UCLB, acts as Director and interim CEO on several of UCLB's spinout companies and oversees the company's licensing activity. Anne is also a member of the Licensing Executives Society (LES) and is on the committee for the Intellectual Property Lawyers Organization (TIPLO).

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

UCL Business

UCL(University College London) is one of the premier universities in the UK for research and innovation, and is dedicated to harnessing its exceptional research for positive social and economic benefit. To this end it has created UCL Business PLC. A wholly-owned subsidiary of UCL, UCL Business (UCLB) has been formed to help industry and business make the most of UCL innovations. Through licensing technologies & innovations, engaging consultancy services, creating shared-risk joint-venture businesses, and utilizing UCL's specialist Subsidiaries, UCL Business promotes and supports the transfer into industry of expertise and knowledge over a wide range of disciplines. To do this, UCLB : Identifies promising new technologies and innovations Promotes UCL expertise and innovations worldwide Offers a single point of contact for business relations with UCL Provides responsive, professional and coherent support for academic/business collaborations, from consultancy through to patent registration, technology licensing and structuring spin-out companies